Carmichael Hill & Associates’s Korro Bio KRRO Stock Holding History

Carmichael Hill & Associates’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$168	Hold	5	–	–	﹤0.01%	763
2024 Q2	$170	Hold	5	–	–	﹤0.01%	762
2024 Q1	$450	Hold	5	–	–	﹤0.01%	741
2023 Q4	$240	Hold	5	–	–	﹤0.01%	773
2023 Q3	$96	Hold	5	–	–	﹤0.01%	779
2023 Q2	$89	Hold	5	–	–	﹤0.01%	779
2023 Q1	$130	Hold	5	–	–	﹤0.01%	770
2022 Q4	$989	Hold	5	–	–	﹤0.01%	723
2022 Q3	$0	Hold	5	–	–	﹤0.01%	844
2022 Q2	$0	Hold	5	–	–	﹤0.01%	844
2022 Q1	$1K	Hold	5	–	–	﹤0.01%	773
2021 Q4	$1K	Hold	5	–	–	﹤0.01%	782
2021 Q3	$2K	Hold	5	–	–	﹤0.01%	751
2021 Q2	$3K	Hold	5	–	–	﹤0.01%	708
2021 Q1	$2K	Hold	5	–	–	﹤0.01%	717
2020 Q4	$9K	Hold	5	–	–	0.01%	570
2020 Q3	$5K	Hold	5	–	–	﹤0.01%	590
2020 Q2	$6K	Hold	5	–	–	﹤0.01%	546
2020 Q1	$5K	Hold	5	–	–	﹤0.01%	531
2019 Q4	$5K	Buy	+5	New	+$3.89K	﹤0.01%	557

Other funds holding KRRO

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Carmichael Hill & Associates's KRRO Position: Q3 2024 in Review

Carmichael Hill & Associates held its Korro Bio (KRRO) position steady in Q3 2024 at 5 shares worth $168. The position accounts for ﹤0.01% of the portfolio, ranked #763.

Carmichael Hill & Associates first reported a position in KRRO in Q4 2019 and has held it in 20 quarters since. The position peaked at $9K in Q4 2020. 71 funds tracked by Wall St. Rank hold KRRO as of Q3 2024.

Carmichael Hill & Associates held 5 shares of Korro Bio worth $168 as of Q3 2024.
Carmichael Hill & Associates left its Korro Bio share count unchanged in Q3 2024.
Korro Bio made up ﹤0.01% of Carmichael Hill & Associates's portfolio in Q3 2024, its #763 holding.
Carmichael Hill & Associates first reported a position in Korro Bio in Q4 2019 and has held it in 20 quarters since.
Carmichael Hill & Associates's Korro Bio position peaked at $9K in Q4 2020.
71 funds tracked by Wall St. Rank held Korro Bio as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.